Blog header.png

Sherpa Clinical Packaging On-Time, On TemperatureTM

Sean Baumstark & De:terminence

A devastating diagnosis understandably brings a halt to life for many people. A moment of overwhelming shock, abrupt grief and a gripling reality of what is to come that most can relate to. Even if never faced with a diagnosis, most of us

Read More

Direct-To-Patient (DTP) Clinical Supply Cheat Sheet

Are you considering Direct-To-Patient Supply Strategies for your clinical trial?

If your answer is YES,  remember to start conversations early.

Early conversations should include:

Read More

Patient Story: Sean Baumstark, Friedreich's Ataxia Survivor

Sean Baumstark is a captivating advocate and a real warrior who has been fighting Friedreich’s Ataxia, a rare, debilitating and life-shortening disease that attacks multiple systems in the body, since the age of 25. Sean will be sharing his story

Read More

OrthoTrophix' Intra-Patient Randomization Design Supported by Advanced Cold-Chain Packaging

Novel drug and trial design generate unique clinical supply management challenges. OrthoTrophix began a two-part, phase 2 clinical trial in February 2014. The first part tested the drug’s safety and efficacy in 27 patients with mild to moderate

Read More

EU GDP Guidelines: Implications for Shipping Clinical Materials into the European Market

March 27, 2018

Change Your Perspective

EU Good Distribution Practice (GDP) require that sponsor companies have a thorough understanding of how clinical supplies are handled and temperature monitored.

For example, do your clinical sites know what

Read More

For the Clinical Supply Field – Some Brexit Answers, More Questions

It is no secret that Brexit will have a large impact on the pharmaceutical industry come March 2019 when the UK exits the EU. Since the UK voted to leave the EU on June 23, 2016, questions have been raised on the logistics of the transition, and

Read More

How to Navigate Clinical Supply for Breakthrough-Designated Drugs

Clinical studies of breakthrough therapy-designated drugs present multiple clinical supply management issues, such as the need to adapt to rolling FDA recommendations regarding clinical study design, endpoints, and study size, even once the study

Read More

PART 3 OF 3: The QP Process Quiz for Clinical Supply Professionals

We've put together a fun little quiz for you to test your Qualified Person (QP) knowledge. If you haven't read our previous blog posts on the QP process, Top Clinical Supply QP Questions Asked At The 2017 Sherpa Summer Seminar and PART 2 OF 3:

Read More

PART 2 OF 3: The QP Role and Annex 16, Stability Data, and Audit Reports

Following up on last week’s Top Clinical Supply QP Questions Asked At The 2017 Sherpa Summer Seminar blog post, below are additional scenarios that your clinical supply colleagues got answered by our expert QP panel at the Sherpa Summer Seminar.

Read More

PART 1 of 3: Top Clinical Supply QP Questions Asked at the 2017 Sherpa Summer Seminar

Any sponsor company planning clinical studies in Europe needs to be prepared for the QP process. Our first blog post outlining the QP processes proved to be one of our most popular blog posts to date. That and the tremendous response we got to

Read More

The Clinical Supply Blog

Welcome to the Sherpa Clinical Packaging Blog! Watch this space for the latest best practices, case studies, and content on everything clinical supply related. If you have a clinical supply topic you would like our opinion on, tell us at


All data and information provided on this site is for informational purposes only. For Sherpa’s full disclaimer, click here.